Accelerator-Based Stereotactic Radiosurgery for Brainstem Metastases
Neurosurgery, 03/28/2012Lin CS et al.
Linear accelerator–based stereotactic radiosurgery (linac–SRS) using a median dose of 14 Gy provided excellent local control in patients with brainstem metastases less than 0.4 mL with relatively low serious morbidity. The results of the study support the use of linac–SRS for patients with brainstem metastases. The authors advocate 14 to 16 Gy, given the high local control rate and low complication rate with this dose.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.